期刊文献+

非活动性肺结核人群的流行病学特征和预防干预 被引量:13

Epidemiology and preventive intervention of inactive tuberculosis
下载PDF
导出
摘要 Houben博士等利用高斯过程回归模型估算我国约有3.5亿人感染结核分枝杆菌(MTB),是世界上MTB感染负担最重的国家之一。2020年,世界卫生组织发布的《结核病综合指南:预防性治疗》中提出“有既往结核病史或者非活动性肺结核病灶者因有更高的发病风险也应该成为暴露后干预的目标人群”。美国和加拿大等国家均将提示有既往肺结核病史的肺部纤维化病灶人群作为潜伏性结核感染检测和治疗的目标人群。目前,我国暂未对有非活动性肺结核人群进行系统干预。考虑到结核病高负担国家和地区可能同样存在较重的非活动性肺结核负担,针对这一高危人群开展活动性结核病的常规监测和早诊早治,并对潜伏性结核感染者开展预防性干预将可能对降低社区发病率做出重要贡献。 China is one of the countries with the highest burden of Mycobacterium tuberculosis(MTB)infection in worldwide with 350 million people were infected as estimated by Dr.Houben and colleagues using Gaussian process regression model.The guidelines on tuberculosis(TB)preventive treatment updated by the World Health Organization in 2020 recommended that“A history of prior TB or TB preventive treatment should not be a contraindication for preventive treatment in case of exposure,following the exclusion of reactivated disease.These individuals,including those with fibrotic radiological lesions,may be at increased risk of progression.”Individuals with chest radiography abnormalities suggestive of prior healed TB has been recommended as targets for latent tuberculosis infection(LTBI)testing and treatment in American and Canada.In countries and areas with high burden of TB,considering the potential high burden of inactive TB,enhancing active case finding and LTBI preventive treatment in this high-risk group might benefit TB incidence decline in a community level.
作者 杜莹 张彬 王大宽 张浩然 辛赫男 金奇 高磊 DU Ying;ZHANG Bin;WANG Da-kuan;ZHANG Hao-ran;XIN He-nan;JIN Qi;GAO Lei(Institute of Pathogen Biology of Chinese Academy of Medical Science(PhD candidate),Beijing 100730,China;不详)
出处 《中国防痨杂志》 CAS CSCD 2020年第11期1232-1236,共5页 Chinese Journal of Antituberculosis
基金 “十三五”国家科技重大专项(2017ZX10201302002) 中国医学科学院医学与健康科技创新工程(2019-I2M-2-005)。
关键词 分枝杆菌 结核 非活动性结核病 人群监测 预防和防护用药 Mycobacterium tuberculosis Inactive tuberculosis Population surveillance Protective agents
  • 相关文献

参考文献3

二级参考文献57

  • 1刘玉清,屠德华,安燕生,张立兴.大学生结核病控制的研究:(二)结核感染者的预防性治疗[J].中国防痨杂志,2005,27(3):139-142. 被引量:94
  • 2Zumla A, George A, Sharma V, et al. Who's 2013 global re- port on tuberculosis: successes, threats, and opportunities. Lancet, 2013, 382(9907): 1765-1767.
  • 3Bennett DE, Courval JM, Onorato I, et al. Prevalence of tu- berculosis infection in the United States population: the na tional health and nutrition examination survey, 1999-2000. Am J Respir Crit Care Med, 2008, 177(3) : 348-355.
  • 4American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep, 2000, 49 (RR 6): 1-51.
  • 5Parekh M J, Schluger NW. Treatment of latent tuberculosis infection. Ther Adv Respir Dis, 2013, 7(6) : 351-356.
  • 6Diel R, Loddenkemper R, Meywal&Walter K, et al. Predic- tive value of a whole blood IFN-gamma assay for the develop- ment of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med, 2008, 177(10): 1164-1170.
  • 7Diel R, Loddenkemper R, Niemann S, et al. Negative and positive predictive value of a whole-blood interferon-3' release assay for developing active tuberculosis: an update. Am J Re spit Crit Care Med, 2011, 183(1): 88-95.
  • 8Haldar P, Thuraisingam H, Patel H, et al. Single step Quan tiFERON screening ofadult contacts: a prospective cohort study of tuberculosis risk. Thorax, 2013, 68(3) : 240-246.
  • 9Bakir M, Millington KA, Soysal A, et al. Prognostic value of a T-cell based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med, 2008, 149 (11): 777-787.
  • 10Aiehelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole blood interferon-gamma release assay in HIV-l-infected individuals. Clin Infect Dis, 2009, 48(7): 954-962.

共引文献44

同被引文献96

引证文献13

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部